Evidence map›Paper›PMID 19716432›Full record

ArticleBiochimica et biophysica acta2009

N-3 polyunsaturated fatty acids suppress insulin-induced SREBP-1c transcription via reduced trans-activating capacity of LXRalpha.

George Howell, Xiong Deng, Chandrahassa Yellaturu, Edwards A Park, Henry G Wilcox, Rajendra Raghow, Marshall B Elam

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Inhibition of cholinergic and non-cholinergic targets following subacute exposure to chlorpyrifos in normal and high fat fed male C57BL/6J mice.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

George HowellDepartment of Pharmacology, University of Tennessee Health Sciences Center, Memphis, TN 38163, USA.
Xiong Deng
Chandrahassa Yellaturu
Edwards A Park
Henry G Wilcox
Rajendra Raghow
Marshall B Elam
University of Tennessee Health Science Center · USMemphis VA Medical Center · US

Funding

Regulation of metabolic gene expressionR01DK059368 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI PARK, EDWARDS A · 2003 to 2011
$2.1M
LIPID/LIPOPROTEIN METABOLISM AND CARDIOVASCULAR DISEASEST32HL007641 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI MALIK, KAFAIT U · 1988 to 2007
$1.8M
Regulation of SREBP-1c Processing by Insulin and Cyclic-AMPR01DK075504 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ELAM, MARSHALL B · 2007 to 2010
$1.1M
Transcriptional Regulation of SREBP-1c by Dietary Polyunsaturated Fatty AcidsF32DK083210 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI HOWELL, GEORGE E · 2008 to 2008
$9k
NHLBI NIH HHS HL 07641-14NHLBI NIH HHS T32 HL007641NIDDK NIH HHS 1F32DK083210-01NIDDK NIH HHS F32 DK083210NIDDK NIH HHS R01 DK059368NIDDK NIH HHS R01 DK075504NIDDK NIH HHS R01-DK75504-01
6 · The paper itself

Abstract

Insulin coordinately up-regulates lipogenic gene transcription via induction of sterol regulatory element binding protein-1c (SREBP-1c). Conversely, polyunsaturated fatty acids (PUFA) decrease lipogenic gene transcription via suppression of SREBP-1c. We therefore examined the ability of n-3 PUFA to mitigate induction of SREBP-1c and its downstream lipogenic targets by insulin in primary rat hepatocyte cultures. Insulin induced expression of SREBP-1c mRNA 5-6 fold as well as rat SREBP-1c promoter activity. These effects were prevented by the n-3 fatty acids eicosapentaenoic acid (20:5 n-3; EPA) and docosahexaenoic acid (22:6 n-3, DHA), but not by the monounsaturated fatty acid oleic acid (18:1 n-6, OLA). N-3 fatty acids also effectively prevented insulin induction of the downstream lipogenic enzyme targets fatty acid synthase (FAS) and acetyl carboxyl coenzyme acetyltransferase-1 (ACC-1), and reduced de novo lipogenesis. The SREBP-1c promoter contains an insulin response unit consisting of tandem LXRalpha response elements (LXREs) as well as sites for NF-Y, Sp1, and SREBP-1c itself. The LXREs were identified as a primary site mediating suppression of SREBP-1c transcription by n-3 PUFA. DHA effectively prevented LXRalpha-dependent activation of both the wild type SREBP-1c promoter and the synthetic LXRE-driven promoter, and significantly blunted LXRalpha-dependent activation of a Gal4-LXRalpha chimeric protein thus demonstrating that n-3 PUFA effectively mitigate induction of SREBP-1c by insulin via reduced trans-activation of LXRalpha.

Indexed as

AnimalsBinding SitesFatty Acids, Omega-3InsulinLipogenesisLiver X ReceptorsLuciferasesMutationOrphan Nuclear ReceptorsRatsResponse ElementsSterol Regulatory Element Binding Protein 1Transcriptional ActivationTranscription, GeneticFatty Acids, Omega-3InsulinLiver X ReceptorsLuciferasesNr1h3 protein, ratOrphan Nuclear ReceptorsSterol Regulatory Element Binding Protein 1

Identifiers

PMID19716432
PMCPMC2783506
OpenAlexW1971661540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.